VERA BRADLEY INC (VRA) Stock Fundamental Analysis

NASDAQ:VRA • US92335C1062

2.85 USD
+0.15 (+5.56%)
Last: Feb 18, 2026, 10:33 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, VRA scores 2 out of 10 in our fundamental rating. VRA was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of VRA is average, but there are quite some concerns on its profitability. VRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year VRA has reported negative net income.
  • In the past year VRA has reported a negative cash flow from operations.
  • In multiple years VRA reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: VRA reported negative operating cash flow in multiple years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -40.00%, VRA is doing worse than 91.11% of the companies in the same industry.
  • VRA has a worse Return On Equity (-76.11%) than 86.67% of its industry peers.
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • The Gross Margin of VRA (45.45%) is worse than 60.00% of its industry peers.
  • VRA's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VRA has less shares outstanding
  • The number of shares outstanding for VRA has been reduced compared to 5 years ago.
  • There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • VRA has an Altman-Z score of 2.22. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.22, VRA is doing worse than 64.44% of the companies in the same industry.
  • VRA has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • VRA has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. VRA outperforms 82.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACCN/A
WACC10.92%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.52 indicates that VRA has no problem at all paying its short term obligations.
  • VRA's Current ratio of 2.52 is fine compared to the rest of the industry. VRA outperforms 71.11% of its industry peers.
  • A Quick Ratio of 0.81 indicates that VRA may have some problems paying its short term obligations.
  • VRA's Quick ratio of 0.81 is on the low side compared to the rest of the industry. VRA is outperformed by 68.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 0.81
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -308.33%.
  • VRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.74%.
  • Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-308.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-29.74%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-22.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.14% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -15.90% on average over the next years. This is quite bad
EPS Next Y-4.11%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-30.39%
Revenue Next 2Y-15.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VRA. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 56.44, the valuation of VRA can be described as expensive.
  • Based on the Price/Forward Earnings ratio, VRA is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of VRA to the average of the S&P500 Index (28.10), we can say VRA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 56.44
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VRA's earnings are expected to grow with 44.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.14%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERA BRADLEY INC

NASDAQ:VRA (2/18/2026, 10:33:55 AM)

2.85

+0.15 (+5.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-11
Earnings (Next)03-10
Inst Owners40.9%
Inst Owner Change-4.99%
Ins Owners14.96%
Ins Owner Change11.87%
Market Cap79.69M
Revenue(TTM)284.73M
Net Income(TTM)-97.47M
Analysts45
Price Target5.61 (96.84%)
Short Float %7.21%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-41.61%
Min EPS beat(2)-170.03%
Max EPS beat(2)86.8%
EPS beat(4)1
Avg EPS beat(4)-209.31%
Min EPS beat(4)-556.97%
Max EPS beat(4)86.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.37%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)-0.08%
Revenue beat(4)0
Avg Revenue beat(4)-5.85%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)-0.08%
Revenue beat(8)0
Avg Revenue beat(8)-8.3%
Revenue beat(12)1
Avg Revenue beat(12)-6.44%
Revenue beat(16)2
Avg Revenue beat(16)-5.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-39.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 56.44
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)0.05
Fwd EY1.77%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS10.18
BVpS4.58
TBVpS4.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.45%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score3
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -111.96%
Cap/Sales 2.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 0.81
Altman-Z 2.22
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)68.99%
Cap/Depr(5y)55.33%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-308.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y-4.11%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.74%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-22.74%
Revenue Next Year-30.39%
Revenue Next 2Y-15.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-279.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-69.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.7%
OCF growth 3YN/A
OCF growth 5YN/A

VERA BRADLEY INC / VRA FAQ

Can you provide the ChartMill fundamental rating for VERA BRADLEY INC?

ChartMill assigns a fundamental rating of 2 / 10 to VRA.


What is the valuation status of VERA BRADLEY INC (VRA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VERA BRADLEY INC (VRA). This can be considered as Overvalued.


How profitable is VERA BRADLEY INC (VRA) stock?

VERA BRADLEY INC (VRA) has a profitability rating of 1 / 10.


Can you provide the financial health for VRA stock?

The financial health rating of VERA BRADLEY INC (VRA) is 4 / 10.